VEGF AND CRP SERUM LEVELS LACK PREDICTIVE VALUE FOR OUTCOMES AS ASSESSED BY CONVENTIONAL RADIOGRAPHS AND MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS TREATED WITH THE TNF INHIBITOR GOLIMUMAB

被引：0
|
作者：
Baraliakos, X. [1 ]
Hermann, K. -G. [2 ]
Xu, S. [3 ]
Hsu, B. [3 ]
Braun, J. [1 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Charite Hosp, Berlin, Germany
[3] Janssen R&D LLC, Spring House, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.3735
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1023
引用
收藏
页码：1138 / 1139
页数：2
相关论文
共 15 条
  • [1] VEGF AND CRP SERUM LEVELS LACK PREDICTIVE VALUE FOR RADIOGRAPHIC AND MRI OUTCOMES IN PATIENTS WITH ACTIVE AS TREATED WITH THE TNF-INHIBITOR GOLIMUMAB
    Baraliakos, X.
    Hermann, K. G.
    Xu, S.
    Hsu, B.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 825 - 825
  • [2] Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab
    Braun, Juergen
    Baraliakos, Xenofon
    Hermann, Kay-Geert A.
    Xu, Stephen
    Hsu, Benjamin
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1704 - 1712
  • [3] SERUM CRP LEVELS DEMONSTRATE PREDICTIVE VALUE FOR RADIOGRAPHIC AND MRI OUTCOMES IN PATIENTS WITH ACTIVE AS TREATED WITH THE TNF-INHIBITOR GOLIMUMAB
    Braun, J.
    Baraliakos, X.
    Hermann, K. -G.
    Xu, S.
    Hsu, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 803 - 804
  • [4] Serum Vascular Endothelial Growth Factor Levels Lack Predictive Value in Patients with Active Ankylosing Spondylitis Treated with Golimumab
    Braun, Jurgen
    Baraliakos, Xenofon
    Hermann, Kay-Geert A.
    Xu, Stephen
    Hsu, Benjamin
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (05) : 901 - 906
  • [5] Vascular Endothelial Growth Factor and C-Reactive Protein Serum Levels Lack Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with the Tumor Necrosis Factor-Inhibitor Golimumab.
    Baraliakos, Xenofon
    Hermann, Kay-Geert A.
    Xu, Stephen
    Hsu, Benjamin
    Braun, Juergen
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1122 - S1122
  • [6] Adalimumab achieve significant improvement in active ankylosing spondylitis patients assessed by magnetic resonance imaging
    Carrasco, J. A.
    Martos, J.
    Guijo, V. Perez
    Font, P.
    Castro, M.
    Munoz, E.
    Munoz, M.
    Miranda, M.
    Ruiz, A.
    Cano, A.
    Collantes, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 391 - 391
  • [7] Do patients with ankylosing spondylitis (AS) without elevated CRP and without active inflammation as detected by magnetic resonance imaging (MRI) respond to TNF alpha blockers?
    Rudwaleit, M
    Schwarzlose, S
    Listing, J
    Brandt, J
    Braun, J
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 336 - +
  • [8] Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after two years of treatment with the anti-TNF agent infliximab
    Baraliakos, X
    Listing, J
    Brandt, J
    Rudwaleit, M
    Sieper, J
    Braun, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 323 - 323
  • [9] Comparing the predictive value of quantitative magnetic resonance imaging parametric response mapping and conventional perfusion magnetic resonance imaging for clinical outcomes in patients with chronic ischemic stroke
    He, Rui
    Zhou, Jia
    Xu, Xiaoyu
    Wei, Xiaoer
    Wang, Feng
    Li, Yuehua
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [10] RETRACTION: Comparing the predictive value of quantitative magnetic resonance imaging parametric response mapping and conventional perfusion magnetic resonance imaging for clinical outcomes in patients with chronic ischemic stroke
    He, R.
    Zhou, J.
    Xu, X.
    Wei, X.
    Wang, F.
    Li, Y.
    FRONTIERS IN NEUROSCIENCE, 2024, 18
12